Outcome, unit | LS mean change from pre-dose to post-dose | LS mean (95% CI) treatment difference | P value* | |
---|---|---|---|---|
BUD/FORM | Placebo | |||
IC, L | 0.256 | − 0.024 | 0.280 (0.218 to 0.342) | < 0.001 |
FEV1, L | 0.187 | − 0.004 | 0.191 (0.150 to 0.233) | < 0.001 |
FVC, L | 0.259 | −0.052 | 0.312 (0.236 to 0.388) | < 0.001 |
FEV1/FVC | 0.017 | −0.002 | 0.019 (0.005 to 0.033) | 0.007 |
VT, mL | 71.90 | 14.28 | 57.62 (29.70 to 85.55) | < 0.001 |
VT/Ti, mL/sec | 26.53 | 3.22 | 23.32 (3.72 to 42.91) | 0.021 |
Ti/Ttot | 0.012 | −0.004 | 0.016 (−0.004 to 0.036) | 0.113 |
RR, breaths/min | −0.19 | −0.43 | 0.24 (− 0.44 to 0.91) | 0.484 |
Ve (RR × VT), mL/min | 838 | −23.9 | 862 (440 to 1284) | < 0.001 |
MBSa | −0.45 | −0.25 | − 0.20 (− 0.45 to 0.05) | 0.106 |